Migræne kliniske forsøg i Washington
5 studier for Migræne søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Northwest Clinical Research Center, Bellevue
- Seattle Children's Hospital Investigational Drug Services, Seattle
- Seattle Children's Hospital, Seattle
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Northwest Clinical Research Center, Bellevue
- Seattle Children's Hospital Investigational Drug Services, Seattle
- Seattle Children's Hospital, Seattle
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
- Cortex Neurovascular / TRA Union, Tacoma
RekruttererObservationsstudie
Alder 18 til 64 · Alle køn · Opdateret 23. sep. 2026 · NCT07652034Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Core Clinical Research /ID# 227904, Everett
- MultiCare Institute for Research and Innovation /ID# 231061, Tacoma
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Seattle Clinical Research Center, Seattle
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.